Replies to post #105358 on Biotech Values

[10nisman]

And I fail to see how this response is stupid. We can just agree to disagree here.

I never said the response was stupid just odd and it would be stupid if Bill Marth was emailing, texting, iChatting a response like to an analyst as it leaves a paper trail. Having Teva's investors relations group addressing the topic that the Company does not respond to questions like that while Bill Marth or whomever within Teva is saying something else can lead to a few issues.

10nis

[HattieTheWitch]

...[then] I guess we have another data point for the delcine in Teva's vaunted credibility...

Are there other recent data points besides Dew's assertion that the patent expiration dates are being misrepresented?